A one year study by the Washington Post has documented 620 cases in which experimental drugs have been implicated in the deaths of cancer patients....And they amount to merely a fraction of the thousands of people who in recent years have died or suffered terribly from cancer experiments.

It will be important to restore those provisions, those disclose provisions, those release provisions so that presidents are indeed held accountable and their information and papers are made public.

And fourthly there is a major shift in public opinion and attitude to accommodate to the post-9/11 mentality and the Bush administration's penchant for secrecy. I think the public has simply become increasingly accustomed to being turned away from vital information and is protesting less and less. You have some squeaky wheels out there, but I don't think they're representative of the population at large.

...In the vast majority of drug experiments, it is not uncommon for none or one or two of hundreds of patients to benefit from the drug.

There are benefits in the sense that there's still a certain level of confidence. But there are liabilities because you can coordinate and manipulate better as the instruments of oversight are more under your control. You don't have so many rogue operations.

Every effort is made to control information. Secrecy is just one of the toggles on their control board. The mindset is in place, and they've done a lot of hiring over eight years, not just political appointees. And they've done a lot of firing or driving people out who might have countermanded or resisted. So, institutionally, it's not going to be simply a matter of flipping the switch to undo it. You're going have to bring in people dedicated to transparency, and you have to demonstrate that there are rewards for candor.

There's no faster way or surer way to consolidate power and disenfranchise critics than to operate in secret. So this plays squarely into the promotion of the unitary executive. That's one factor.